Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-08-19 | NOVAVAX INC | Trizzino John
(EVP, CCO and CBO) |
M | Common Stock | A | 655 | $0.00 - $0.00 | $0 |
2024-08-19 | NOVAVAX INC | Trizzino John
(EVP, CCO and CBO) |
F | Common Stock | D | 317 | $13.90 - $13.90 | $4,406 |
2024-08-16 | NOVAVAX INC | Kelly James Patrick
(EVP, CFO and Treasurer) |
M | Common Stock | A | 2367 | $12.96 - $12.96 | $30,676 |
2024-08-16 | NOVAVAX INC | Kelly James Patrick
(EVP, CFO and Treasurer) |
F | Common Stock | D | 1223 | $12.96 - $12.96 | $15,850 |
2024-06-17 | NOVAVAX INC | Dubovsky Filip
(President, R&D) |
S | Common Stock | D | 13904 | $14.46 - $14.54 | $201,164 |
2024-06-17 | NOVAVAX INC | Dubovsky Filip
(President, R&D) |
M | Common Stock | A | 13904 | $6.09 - $6.97 | $85,910 |
2024-06-12 | NOVAVAX INC | King Rachel K.
(Director) |
M | Common Stock | A | 6670 | $0.00 - $0.00 | $0 |
2024-06-12 | NOVAVAX INC | MOTT DAVID M
(Director) |
M | Common Stock | A | 6670 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |